Name
Purdue University Globle
NU581 FNP II Clinical – Children and Adolescent Health Focus
Prof. Name
Date
Acute bacterial sinusitis (ABS) in children is diagnosed primarily through clinical symptoms and their duration. The diagnosis is most likely when upper respiratory symptoms persist for more than 10 days without improvement, severe symptoms such as high fever and purulent nasal discharge develop, or symptoms worsen after an initial period of recovery. Amoxicillin-clavulanate is the recommended first-line antibiotic for most children with uncomplicated acute bacterial sinusitis who do not have a penicillin allergy. Prompt recognition and appropriate management can help reduce the risk of complications involving the eyes, brain, and surrounding facial structures.
Acute bacterial sinusitis is an infection of the paranasal sinuses caused by bacteria. In pediatric patients, it often develops following a viral upper respiratory infection. The condition may occur during infancy, childhood, or adolescence and is generally diagnosed through the child’s history and physical examination rather than routine laboratory testing or imaging.
The paranasal sinuses are air-filled spaces located around the nose and eyes. Inflammation and mucus accumulation can interfere with normal sinus drainage, allowing bacterial infection to develop in some children.
Acute bacterial sinusitis is commonly classified as acute when symptoms last less than 30 days, although the clinical diagnosis depends more on the characteristic symptom pattern than on duration alone.
Healthcare providers generally use three clinical presentations to identify pediatric acute bacterial sinusitis:
Persistent symptoms without improvement.
Severe symptoms at the beginning of the illness.
Worsening symptoms after initial improvement.
Persistent illness is one of the most common diagnostic patterns. A child may have symptoms of an upper respiratory infection that continue for more than 10 days without showing meaningful improvement.
Typical findings include:
Nasal congestion or obstruction.
Nasal discharge that continues for 10 days or longer.
Daytime or nighttime cough.
Facial pressure or discomfort, particularly in older children.
A prolonged cough or runny nose alone does not always indicate bacterial sinusitis. The lack of improvement over time is an important part of the diagnostic assessment.
Severe onset occurs when significant symptoms develop at the beginning of the illness. The classic clinical pattern includes:
Fever of at least 39°C (102.2°F).
Purulent nasal discharge.
Symptoms continuing for at least three consecutive days.
A child with this presentation should receive prompt clinical evaluation. Severe symptoms may indicate a bacterial infection that requires antibiotic treatment rather than continued observation alone.
Worsening symptoms, sometimes called “double sickening,” occur when a child initially improves from a viral respiratory infection and then develops new or more severe symptoms.
Possible signs include:
Increasing nasal congestion.
Worsening cough.
New or recurrent fever.
Increased facial pain or upper jaw discomfort.
Progressive fatigue or irritability.
This pattern may suggest a secondary bacterial infection and should prompt reassessment by a healthcare professional.
Routine imaging is not recommended for uncomplicated acute bacterial sinusitis in children. Diagnosis is generally based on clinical symptoms, symptom duration, and physical examination findings.
Imaging may be considered when complications or an alternative diagnosis are suspected. Examples include:
Orbital complications, such as swelling around the eye or changes in vision.
Suspected intracranial or central nervous system involvement.
Abscess formation.
Persistent or recurrent disease that does not respond to appropriate treatment.
Suspected anatomical abnormalities.
Computed tomography (CT) may be used to evaluate suspected orbital or intracranial complications because it provides detailed images of the sinuses and nearby structures. Imaging decisions should be individualized according to the child’s clinical condition.
Amoxicillin-clavulanate is the recommended first-line antibiotic for most children with acute bacterial sinusitis. It provides activity against common bacterial pathogens associated with pediatric sinus infections, including organisms that may produce beta-lactamase enzymes.
Antibiotic treatment should be prescribed based on the child’s age, weight, clinical severity, allergy history, and relevant risk factors.
For children aged 3 months and older who weigh less than 40 kg, a commonly recommended standard-dose regimen is:
Dose: 45 mg/kg/day of the amoxicillin component.
Frequency: Divided into two doses administered every 12 hours.
Duration: Often 10 days, with treatment duration individualized according to clinical response and provider recommendations.
The American Academy of Pediatrics guideline also identifies high-dose amoxicillin-clavulanate, 90 mg/kg/day of the amoxicillin component divided into two doses, for selected children at increased risk of resistant bacterial infection or treatment failure.
The appropriate dose depends on several factors:
The child’s current weight.
The concentration of the prescribed formulation.
The severity of the illness.
Recent antibiotic exposure.
Risk of resistant organisms.
Renal function and other medical conditions.
Important: The dosing information above is educational. Parents and caregivers should not calculate or change a child’s antibiotic dose without guidance from a qualified healthcare professional.
Children with a penicillin allergy may require a different antibiotic. The choice depends on whether the allergy is mild or severe, the history of anaphylaxis, local bacterial resistance patterns, and the child’s clinical condition.
For children with a non-type I penicillin allergy, certain oral cephalosporins may be considered by the treating clinician. Examples include cefuroxime and cefpodoxime.
For children with a serious immediate hypersensitivity reaction to penicillin, such as anaphylaxis, the clinician may consider other antibiotic options, including clindamycin combined with an appropriate cephalosporin when indicated by current guidelines and specialist advice.
The exact antibiotic choice should be individualized. Clindamycin alone may not provide reliable coverage for all common bacterial causes of pediatric sinusitis, particularly Haemophilus influenzae, so it should not automatically be treated as a universal first alternative.
Macrolides, such as azithromycin, are generally not recommended for routine empiric treatment because resistance among common sinusitis pathogens can limit their effectiveness.
Referral to a pediatric specialist or otolaryngologist (ENT) may be appropriate when the child’s symptoms do not improve with suitable treatment or when complications are suspected.
Referral should be considered for:
Persistent symptoms despite appropriate antibiotic therapy.
Progressive or recurrent sinus infections.
Suspected anatomical abnormalities.
Complications involving the orbit or central nervous system.
Significant underlying immune deficiency.
Chronic or recurrent sinus disease requiring further evaluation.
Children with suspected orbital or intracranial complications require urgent medical assessment rather than routine outpatient referral.
Supportive treatment helps improve comfort while the infection resolves. It may be used alongside prescribed antibiotic therapy when bacterial sinusitis has been diagnosed.
Saline nasal drops or sprays may help loosen mucus and relieve nasal congestion. Age-appropriate saline irrigation can also support nasal hygiene and improve comfort.
Caregivers should use safe irrigation practices and follow pediatric recommendations, particularly for younger children.
Adequate fluid intake helps prevent dehydration and supports overall recovery. Humidified air may provide temporary relief from nasal irritation, although it does not treat the bacterial infection itself.
Intranasal corticosteroids may be considered in selected children, particularly those with allergic rhinitis or significant nasal inflammation. They may help reduce congestion and improve nasal symptoms in some patients.
These medications should be used according to the child’s age, the prescribed product, and healthcare provider guidance.
Children with severe illness, complications, or failure of appropriate outpatient treatment may require additional interventions.
Possible treatments include:
Intravenous antibiotic therapy.
Intramuscular ceftriaxone in selected clinical situations.
Hospital admission for monitoring and treatment.
Surgical drainage or other procedures when abscesses or serious complications develop.
Surgery is not routinely required for uncomplicated acute bacterial sinusitis. It is generally reserved for selected complicated or refractory cases.
A child who worsens or fails to show improvement within approximately 72 hours of starting antibiotic therapy should be reassessed by a healthcare professional.
Possible reasons for treatment failure include:
Incorrect diagnosis.
Poor medication adherence.
Resistant bacterial organisms.
Inadequate antibiotic coverage.
Complications.
An underlying condition affecting recovery.
The clinician may consider:
Confirming that the prescribed antibiotic and dose are appropriate.
Reviewing medication adherence.
Changing to an appropriate alternative or broader-spectrum antibiotic.
Evaluating for resistant organisms or other diagnoses.
Assessing for orbital or intracranial complications.
Referring the child to a specialist when indicated.
Children who deteriorate clinically may require emergency evaluation, hospital admission, and intravenous or intramuscular antibiotic treatment.
Observation for up to three days may be considered in selected children with persistent, nonsevere symptoms when the child is clinically stable and reliable follow-up is available.
Observation is most appropriate when:
Symptoms are mild or nonsevere.
The child remains adequately hydrated.
There are no signs of orbital or intracranial complications.
Caregivers can monitor the child’s condition.
Follow-up is readily available.
For children with persistent symptoms, the clinician may offer either antibiotic treatment immediately or a brief period of observation, depending on the clinical assessment and shared decision-making with caregivers.
Observation is not appropriate for children with severe onset symptoms, significant clinical deterioration, or suspected complications.
A healthy four-year-old with clinically diagnosed acute bacterial sinusitis may receive amoxicillin-clavulanate when antibiotic treatment is indicated.
Supportive care may include saline nasal spray, appropriate hydration, and symptom monitoring.
Treatment duration should be individualized. A 10-day course may be used in some children, but the appropriate duration depends on clinical response and current pediatric recommendations.
Children with immune deficiency may be at increased risk for severe, recurrent, or complicated infections. Their management requires a more comprehensive assessment.
Clinical considerations include:
Reviewing previous infections and antibiotic exposure.
Evaluating immune status.
Monitoring for complications.
Considering earlier consultation with a pediatric infectious disease specialist or immunologist.
Individualizing antibiotic selection and treatment duration.
A history of two prior sinus infections does not automatically establish chronic or recurrent bacterial sinusitis. However, repeated episodes warrant a review of the child’s clinical history.
Healthcare providers may assess:
Previous antibiotic treatments and response.
Allergy history.
Vaccination status.
Underlying respiratory conditions.
Anatomical abnormalities.
Frequency and duration of infections.
Further evaluation may be needed if infections continue to recur or fail to resolve appropriately.
Cystic fibrosis is associated with thick respiratory secretions and chronic airway disease, which can contribute to recurrent upper and lower respiratory infections.
Management may include:
Airway clearance therapies.
Antibiotic treatment guided by clinical findings and, when appropriate, microbiological results.
Multidisciplinary care.
Follow-up with a cystic fibrosis or pulmonary specialist.
Assessment for chronic sinus disease and other respiratory complications.
Treatment should be coordinated with the child’s specialist team because antibiotic selection and airway management may differ from those used for otherwise healthy children.
Several underlying conditions can affect the diagnosis, treatment, and prognosis of pediatric acute bacterial sinusitis.
These include:
Immune deficiencies.
Cystic fibrosis.
Chronic pulmonary disease.
Recurrent respiratory infections.
Anatomical abnormalities.
Recent antibiotic exposure.
Incomplete vaccination status.
Conditions associated with impaired sinus drainage.
Identifying these factors helps clinicians develop an individualized management plan and determine whether additional testing, specialist referral, or closer monitoring is necessary.
Acute bacterial sinusitis in children is primarily a clinical diagnosis. The three characteristic presentations are persistent symptoms lasting more than 10 days without improvement, severe onset with high fever and purulent nasal discharge, and worsening symptoms after initial recovery.
Amoxicillin-clavulanate is the standard first-line antibiotic for most children without penicillin allergy. Alternative antibiotics may be appropriate for selected children with allergies or other risk factors. Routine imaging is unnecessary in uncomplicated cases, while CT or other investigations may be indicated when complications are suspected.
Reassessment is important when symptoms fail to improve or worsen after antibiotic treatment. Children with immune deficiencies, cystic fibrosis, recurrent infections, or suspected complications may require individualized management and specialist consultation.
It is diagnosed clinically when a child has persistent upper respiratory symptoms for more than 10 days without improvement, severe symptoms such as fever of at least 39°C and purulent nasal discharge for three or more days, or worsening symptoms after initial improvement.
Amoxicillin-clavulanate is the recommended first-line antibiotic for most children with acute bacterial sinusitis who do not have a penicillin allergy.
No. CT imaging is not routinely needed for uncomplicated acute bacterial sinusitis. Imaging is considered when orbital, intracranial, anatomical, or other complications are suspected.
Double sickening refers to worsening symptoms after a child initially begins to recover from a viral upper respiratory infection. It may include new fever, worsening cough, increased congestion, or facial discomfort.
The child should be reassessed by a healthcare professional. The clinician may review adherence, confirm the diagnosis, evaluate for complications, and adjust treatment when appropriate.
American Academy of Pediatrics. (2013). Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics, 132(1), e262–e280. https://doi.org/10.1542/peds.2013-1071
Hauk, L. (2014). AAP releases guideline on diagnosis and management of acute bacterial sinusitis in children one to 18 years of age. American Family Physician, 89(8), 676–681. https://www.aafp.org/pubs/afp/issues/2014/0415/p676.html
Leung, A. K. C., Hon, K. L., & Chu, W. C. W. (2020). Acute bacterial sinusitis in children: An updated review. Drugs in Context, 9, 2020-9-3. https://doi.org/10.7573/dic.2020-9-3
Drugs.com. (2020). Amoxicillin/clavulanate dosage guide + max dose, adjustments. https://www.drugs.com/dosage/amoxicillin-clavulanate.html
